Use the links below to download posters from our international meetings.

Click here to learn more about the poster presentation submission process.


2023-2024 Medicare Part D Coverage Update

A Real-World Comparative Effectiveness Analysis of Fostamatinib VS. Thrombopoietin Receptor Agonists (PTOs) for Treatment of Chronic Immune Thrombocytopenia in Adult Patients

Ajufo_SOHO2023_Landmark OS SVR

Biodistribution and Shedding Analysis Following Treatment with RP1 Oncolytic Immunotherapy in the Skin Cancer Patients from the IGNYTE Clinical Trial

Cancer Health Disparities- Addressing Unmet Screening Needs in a Community Cancer Clinic

Carboplatin Case Study on Impact of Oncology Drug Shortages

Cause of Death and Prognosis of Patients With Primary Refractory Disease, and Prognosis of Patients Reaching PFS24

Comparison of Discontinuation Rates in Patients Receiving an Oral Anticancer Agent Before and After Implementation of a 14 day Pharmacist Checkin Protocol

Concordance Between Solid Tissue and Liquid Biopsy for Gene Mutations in Advanced Cancer Patients- Single Center Study

Corganics Clinical CBD

Current Status and Future Perspectives of Precision Oncology in Greece

Development and Characterization of Bigels for Topical Applications

Drug Shortage Management in Community Oncology- Ensuring Access to Vital Medications 

Efficacy of Pacritinib for Spleen, Symptoms, and Anemia Benefit in Myelofibrosis Patients Across the Cytopenic Spectrum

Ellagic Acid Induces Apoptosis in Neuroblastoma via Multiple Signaling Pathways

Empowering Cancer Patients- Reducing Financial Barriers through Pharmacist-Led Counseling (NOLA Initiative Case Study)

Enhancing Immunotherapy Efficacy with the Use of Antihistamines in Cancer Patients-A Review of Published Studies

Evaluating the Impact of Continuous Infusion Chemotherapy Titration Protocol on Administration Time and Length of Stay in Inpatient Oncology Unit

Exploring the Impact of Dietary Factors on Colorectal Cancer- A Review of Published Research

Final Prespecified Overall Survival Analysis of CLEAR- 4-Year Follow-Up of Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma

Financial Impact of Integrated Specialty Pharmacy Efforts to Avoid Oral Oncolytic Waste

Futibatinib in Patients With FGFR2-Rearranged Intrahepatic Cholangiocarcinoma- Responder Analyses of Efficacy and Safety From the Phase 2 FOENIX-CCA2 Study

Glofitamab in Patients With Relapsed Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies

Growth of NCODA Professional Student Organization Chapters

Health-Related Quality of Life Associated with Trifluridine:tipiracil in Combination with Bevacizumab in Refractory Metastatic Colorectal Cancer- An Analysis of the Phase III SUNLIGHT Trial

Identification of Practitioner Needs when Caring for Patients Taking Oral Anticancer Medications

Impact of Nirogacestat on Pain, a Key Symptom in Patients With Desmoid Tumors- Results From the Phase 3 DeFi Study

Increasing Accessibility for Hispanic Cancer Patients

Independent Health Advocacy

Initial Efficacy and Safety Results from ENGOT-ov60 GOG-3052 RAMP 201

Legislative and Policy Advisory Committee (LPAC)

Letermovir for Cytomegalovirus Prophylaxis in Patients Post Hematopoietic Stem Cell Transplant

Maintained ECOG-PS with Trifluridine-tipiracil in Combination with Bevacizumab in Refractory Metastatic Colorectal Cancer- An Analysis of the Phase III SUNLIGHT Trial

Managing Medication Inventory as a Pharmacy Technician

Maximizing Cost Savings – The Impact of Specialty Pharmacist Interventions at a Community Oncology Center

Medically Integrated Pharmacy – Enhancing the Patient Experience

Mosunetuzumab Monotherapy Demonstrates Durable Efficacy With a Manageable Safety Profile in Patients With Relapsed Refractory Follicular Lymphoma Who Received ≥2 Prior Therapies

National Results of Utilizing the NCODA Cost Avoidance and Waste Tracker Tool – An Online Method of Identifying and Preventing Drug Waste

Navigating Diagnostic Challenges – Hemophagocytic Lymphohistiocytosis (HLH) in the Context of Sepsis and Cancer Management

NCODA 2023 RAMP 201 Part A Encore

NCODA Nursing Community

NCODA Positive Quality Interventions (PQI)

NCODA PQI Smoking Cessation

NCODA Webinar Series

NCODA, Expanding Oncology Care to Uganda and Africa

Non-Pharmacological Management of Anxiety in Cancer Patients

Nursing Education Series Led by the Specialty Pharmacy Team

Oncology Pharmacy Technician Association (OPTA)

Optimizing Venous Thromboembolism Prophylaxis in Cancer Patients- A Retrospective Study Based on Khorana Score Assessment and Anticoagulation Prescriptions

Outcomes of Patients with Myelofibrosis and Elevated Peripheral Blood Blasts Treated with Pacritinib on Phase 2:3 Trials

Patient Assistance Made A Top Priority

Patients’ Perspectives on Oral Decitabine and Cedazuridine for the Treatment of Myelodysplastic Syndromes

Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Following EGFR TKI and Platinum-Based Chemotherapy- HERTHENA-Lung01

PFAS Contamination and Cancer – An Emerging Concern

Poly (ADP-RIBOSE) Polymerase Inhibitor (PARPi) Therapy. Retrospective Analysis of Adverse Events and Treatment Modifications During the First 90 Days of Therapy

Providing Proactive Care for Patients Taking Oral Oncolytics to Minimize Adverse Reactions and Optimize Adherence

Regulatory Approval of Oncolytic Biosimilars- A Comparative Analysis of Alymsys and Zirabev

Risk of Severe Toxicity from Topical Fluoropyrimidine Treatment in Patients Carrying DPYD Variant Alleles

RSV In Immunocompromised Patients

Student Impact on Quality Improvement Initiative- IMiD Therapy Adherence Assessment

System-Wide Collaborative Oncology Nurse Navigation

Teamwork in Healthcare

The Life Cycle of an Oral Oncolytic in the MID – IOD Setting

The Role of Erythropoietin Stimulating Agents (ESAs) in the Treatment Landscape of Myelodysplastic Syndrome (MDS)

The Role of Guideline Directed Medical Therapy in Trastuzumab Induced Heart Failure and Cardiotoxicity

The Role of SBRT in Recurrence in Liver Post Liver Transplant Patient (cholangiocarcinoma) – A Case Report of Cholangiocarcinoma – One of the Rarest and Longest Ever Reported Case Study

The Value Of Oncology Trained Nurses in a Medically Integrated Pharmacy Continuing the Cancer Care Continuum, Maximizing Cost Avoidance and Reducing Waste of Oral Oncolytic Medications

Treatment Support Kits (TSK)


A Case of AL Amyloid that Initially Presented as new Onset Heart Failure with Preserved Ejection Fraction

A Punch to the Gut- Antibiotics May Diminish the Therapeutic Effect of Immune Checkpoint Inhibitors

Advancing Cannabinoid Education & Science Study

Benefits of a Integrated Pharmacy Help Desk

Biosimilar Uptake and Cost Savings Analysis Before and After Implementation of a Pharmacist-driven Substitution Program within a National Community Oncology Network

Cancer Related Fatigue

Clinical Utility and The Role of Widespread and Broad Based Pan-Cancer Germline Testing (Outside of Current Guidelines) in Community Cancer Clinics

Comparing Acalabrutinib and Ibrutinib in the Real World- A Study of 2,509 Patients with Chronic Lymphocytic Leukemia

Defining FOXR1 Expression and Function in Cancer

Expansion Analysis of a Grassroots Oncology Organization

Expansion of Oncology Pharmacy Practice Through Bruton’s Tyrosine Kinase Inhibitor Cardiovascular Assessments

Fatalities from Tumor Lysis Syndrome (TLS) After Anti-Hyperuricemic Monotherapy – Nationally Representative, Propensity Score Matched, Retrospective Study Comparison of Rasburicase and Allopurinol

Growth of NCODA Professional Student Organization Chapters

Guideline and Standard Development for Medically Integrated Dispensing Pharmacies for Oral Anticancer Medication- ASCO_NCODA Standards 

How Specialty Pharmacy Enhances The Patient Experience

If Every Patient Were the Same, Then Treatments Would Be Too

Impact of an Analytics Intervention on G-CSF Prescription Turnaround in Speciality Pharmacy

Impact of Ribociclib Dose Modifications on Overall Survival in Patients with HR+_HER2 – Advanced Breast Cancer in MONALEESA-2

Infusion-related Reactions with Nivolumab and Pembrolizumab- A Case Series Analysis

Interim Analysis from ELEANOR- A Multi-national, Prospective, Non-interventional Study Among Patients with HER2+ and HR+ Early Breast Cancer Treated with Extended Adjuvant Neratinib in the Clinical Routine

K-RAS-tling with Resistance- KRASG12C Inhibitors and Strategies for Overcoming Resistance

Managing Oral Chemo Compliance

Medically Integrated Patient Assistance For Oncology

Metformin (MET) for the prevention of Alpelisib (ALP)-related Hyperglycemia (HG) in PIK3CA-mutated, Hormone Receptor-Positive (HR[+])_HER2-Negative (HER2[-]) Advanced Breast Cancer (ABC)- The METALLICA study

National Results of Utilizing the NCODA Cost Avoidance and Waste Tracker Tool- An Online Method of Identifying and Preventing Drug Waste

NCODA International Monthly Webinar

NCODA Nursing Community

NCODA Oral Oncolytics Adherence Assessment

Oncology Basics Course- On-Demand Refresher for Pharmacy Trainees

Oncology Pharmacy Technician Association (OPTA)

Pacritinib is a Potent ACVR1 Inhibitor with Significant Anemia Benefit in Patients with Myelofibrosis

Pharmacy Student Perspectives On Oncology Education

Planning for the Future- A Review of Cancer in Pregnancy and Fertil

Positive Quality Interventions (PQI)- Idea to Implementation

Positive Quality Interventions in Action

Quality of Life with Ribociclib Plus Aromatase Inhibitor vs Abemaciclib Plus Abemaciclib Plus Aromatase Inhibitor as First-Line Treatment of HR+_HER2

Review of Biosimilar Legislation Activity at State and Federal Level in the United States Between 2018 and 2022


Starting an Interprofessional PSO Chapter as a Distance Student

The Future of Combination Immunotherapy for Cancer Treatment

The Road map to success in the Value Based Care Models

The role of Social Determinant of Health (SDoH) and Health Related Social Needs (HrSN) data in addressing Cancer Health Disparities

Treatment Support Kits Supportive Care Provided for Patients

Updated Expert Consensus Recommendations for Managing Hyperglycemia and Rash in Patients With PIK3CAMutated, Hormone Receptor- Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Advanced Breast Cancer Treated With

Use of a Validated AML Composite Score Measuring Fitness and Cytogenetic Risk to Assess Outcomes in 1L AML Patients Receiving Venetoclax Plus Azacitidine in VIALE‑A

Utility of the Layer-by-layer Technique in Photodynamic Therapy to Enhance Photodynamic Efficacy


Cost Avoidance Waste Tracker

Positive Quality Interventions

PQI in Action

OCE Sheets

IVE Sheets

Treatment Support Kits

PQI Podcast


Member Resources



Member Login



Spring Forum

Oncology Institute

PSO Annual Meeting

Fall Summit


P.O. Box 468
Cazenovia, NY 13035

NCODA is a 501(c)(3) Organization